RE:RE:RE:4.08 down RED again - down 43% in a weekGet lost you paid spammer you know nothing like everyone else on this board. According to you LMNL was going to shut down in May...no more money...no FDA aproval...SALP is selling bla bla bla! Why don't you share with us the details of the contract with Kedrion. What a fkng loser.
If they get $70M PRV + $22M USD for the plasma business, I don't see this as a terrible deal if this business is no longer part of their future vision. Yea,Yea, I know, why invest all the money to suddenly let it go ? Good question, perhaps new management figured that the cost to commercialize wasn't worth the return and it made more sense for Kedrion who has the infrastructure in place!
What's next? Take it private, I doubt it. Sell the business, most likely, the signs seem to point in this direction. I'll take what ever comes, perhaps I will become a shreholder of a new company...who the fk knows...certainly not you .I.
4Justice wrote: His third brilliant post. he didn't realized that they pay to get rid of the golden goose. May be they will have some money from the voucher but nothing more. The hiring process is just an obligation relating to maintaining the operations for whichthey are responsable according to the sales contract thet no one seems to have read!
tommyjones1 wrote: imo sp is very attractive, market cap around 120M$, quiet low for a company with a FDA approved drug about to launch, on any news of kedrion or voucher, upside could be substantial. They are also hiring production people, negociation with insurance companies normally happen before a FDA decision is du, to... start production once FDA gives a green light. They are hiring for a reason.
i think this is a very good and cheap spec stock.
stockbuphoon wrote:
Great performance down from $12 rights offering in 2 years of under new management.
The company said that their goal was to sell any voucher within 2021 so they understand that they take time to sell. Clown who posts 50 times a day says 2 weeks. Who is right? Clown or management? I think mgmt is actually right here for a change.
producing Ryplazim with no insurance companies to pay for orphan drug costs? I guess that happens automatically, too. What a keen business mind he has. Hilarious if it weren't so pathetic